Skip to main content
. Author manuscript; available in PMC: 2014 Feb 5.
Published in final edited form as: Acta Neuropathol. 2013 Aug 31;126(4):537–544. doi: 10.1007/s00401-013-1171-0

Table 1.

Description of three subtypes characterised by GGIs

Subtypes Regional distribution of oligodendroglial inclusions GOIs CBs GAIs AHC Clinical features Common clinical diagnoses Previous reports
Type I FT +++ + + - FLF and/or Dem FTD, PiD [1-3, 6, 10, 13, 18, 21]
Type II MTR and/or CST ++ ++ + ± FLF, PF and/or EPF PSP, CBS, MND, PLS [1, 12]
Type III FT, MTR and/or CST ++ ++ +++ ++ FLF, Dem, MND and/or EPF PSP, CBS, MND [7, 20]

GOIs globular oligodendroglial inclusions, CBs coiled body-type inclusions, GAIs globular astrocytic inclusion, AHC anterior horn cell involvement (neuronal loss and tau pathology), FT frontotemporal, FLF frontal-lobe features, Dem dementia, FTD frontotemporal dementia, PiD Pick's disease, MTR motor cortex, CST corticospinal tract, PF pyramidal features, EPF extrapyramidal features, PSP progressive supranuclear palsy, CBS corticobasal syndrome, PLS primary lateral sclerosis, MND motor neuron disease features, - negative/absent, + low severity, ++ moderate severity, +++ high severity

HHS Vulnerability Disclosure